Abstract
To assess whether the Lowry-tetramethylurea method for measuring apolipoprotein B-100 (apo-B) in very low density lipoprotein (VLDL) could be replaced by direct assay of VLDL apo-B using a highly practicable immunological method. Seventy five fasting blood samples were collected from patients attending the lipid clinic at this hospital. Plasma was separated immediately and VLDL isolated by preparative ultracentrifugation at solution density 0.93-1.006 kg/l. Apo-B was precipitated from an aliquot of the VLDL fraction using the tetramethylurea (TMU) technique and protein mass determined by the Lowry method (LM); mean apo-B 83.02 micrograms/ml (SD 74.85). Apo-B was also measured in VLDL using direct immunoturbidimetry on the Cobas-Fara analyser; mean apo-B 82.32 micrograms/ml (SD 72.88). There was a very close correlation between methods (immunoturbidimetry = 0.94.LM + 3.95, r = 0.97, p < 0.001). The mean difference between methods (constant error) was small (0.70 microgram/ml) and not significant (p = 0.742). Random error was 13.01 micrograms/ml by analysis of variance. It is concluded that immunoturbidimetry, a more rapid and convenient test, may replace the LM and TMU techniques for measuring VLDL apo-B concentration and that this method could be applied to research studies requiring analysis of large numbers of samples.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bhatnagar D., Durrington P. N. Clinical value of apolipoprotein measurement. Ann Clin Biochem. 1991 Sep;28(Pt 5):427–437. doi: 10.1177/000456329102800501. [DOI] [PubMed] [Google Scholar]
- Brustolin D., Maierna M., Aguzzi F., Zoppi F., Tarenghi G., Berti G. Immunoturbidimetric method for routine determinations of apolipoproteins A-I and B. Clin Chem. 1991 May;37(5):742–747. [PubMed] [Google Scholar]
- Calvert G. D., Yeates R. A., Roeger D. C. Electroimmunoassay of a subunit protein in a macromolecular complex (apolipoprotein B in human plasma very low density lipoprotein); implications for other electroimmunoassay systems. Clin Chim Acta. 1979 Oct 1;97(2-3):135–142. doi: 10.1016/0009-8981(79)90409-1. [DOI] [PubMed] [Google Scholar]
- Chien K. R., Knowlton K. U. Cardiovascular molecular biology. Introduction to the series. Circulation. 1989 Aug;80(2):219–233. doi: 10.1161/01.cir.80.2.219. [DOI] [PubMed] [Google Scholar]
- Kane J. P., Sata T., Hamilton R. L., Havel R. J. Apoprotein composition of very low density lipoproteins of human serum. J Clin Invest. 1975 Dec;56(6):1622–1634. doi: 10.1172/JCI108245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Labeur C., Shepherd J., Rosseneu M. Immunological assays of apolipoproteins in plasma: methods and instrumentation. Clin Chem. 1990 Apr;36(4):591–597. [PubMed] [Google Scholar]
- Mount J. N., Kearney E. M., Rosseneu M., Slavin B. M. Immunoturbidimetric assays for serum apolipoproteins A1 and B using Cobas Bio centrifugal analyser. J Clin Pathol. 1988 Apr;41(4):471–474. doi: 10.1136/jcp.41.4.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ordovas J. M., Peterson J. P., Santaniello P., Cohn J. S., Wilson P. W., Schaefer E. J. Enzyme-linked immunosorbent assay for human plasma apolipoprotein B. J Lipid Res. 1987 Oct;28(10):1216–1224. [PubMed] [Google Scholar]